Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results
Go back to Intra-Cellular Therapies Provides Corporate Update and Reports Third Quarter 2018 Financial Results| INTRA-CELL THRP (NASDAQ: ITCI) | Delayed: 131.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $131.87 | 52 Week High | $59.96 | |||
| Open | $131.87 | 52 Week Low | $10.80 | |||
| Day High | $131.87 | P/E | N/A | |||
| Day Low | $131.87 | EPS | $0.00 | |||
| Volume | 101 | |||||
